The consumer price index surged 6.2% year-over-year last month, its highest gain since 1990, driving investors’ inflation concerns. While other, positive, economic data should power the stock market, concerns over rising inflation could…
foster significant volatility in the near term.
However, according to Suze Orman, a popular personal finance expert, “Over the long-term, stocks have produced the best gains after factoring in inflation. Bonds and cash struggle to keep pace with inflation; only stocks have a track record of earning more than inflation.” Furthermore, Fed officials have reiterated that the rally in commodity prices is temporary, owing to production and delivery bottlenecks caused by the COVID-19 pandemic. Since the gridlock-driven inflation is expected to abate in the near term, we think investing in low-priced stocks gradually could churn out greater returns.
Therefore, it could be wise to add Globalstar, Inc. (GSAT – Get Rating), OPKO Health, Inc. (OPK – Get Rating), and Energous Corporation (WATT – Get Rating) to one’s watch list now. These stocks are trading at less than $5, and Wall Street analysts expect them to deliver significant returns in the near term.
A pioneer of mobile satellite voice-data services, GSAT in Covington, La., provides mobile satellite services worldwide. It is a leading global provider of customizable Satellite IoT Solutions to industries that include oil and gas, transportation, emergency management, and others.
On October 19, 2021, GSAT announced the deployment of its SmartOne Solar satellite IoT transmitter to provide satellite tracking for leisure boat owners. Co-Founder and Managing Director of Advanced Tracking, Christophe Allan, said, “We knew that by integrating SmartOne Solar, we’d have the ideal solution to provide cost-conscious boat owners with an affordable, high-quality solution to track their vessels.”
For the third quarter, ended September 30, 2021, GSAT’s subscriber equipment sales increased 9% year-over-year to $4.77 million. Its total revenue came in at $32.61 million, up 7.7%, sequentially. The company’s total operating expenses were $47.33 million, compared to $47.39 million in the year-ago period.
GSAT’s revenue is expected to be $121.35 million in its fiscal year 2022, representing a 1.5% year-over-year rise. The company’s EPS is expected to increase 16.7% in the next year and 15% per annum in the next five years.
Over the past six months, the stock has gained 42.2% in price to close yesterday’s trading session at $1.55. Wall Street analysts expect the stock to hit $3.25 in the near term, which indicates a potential 109.7% upside.
Healthcare company OPK, in Miami, Fla., does business mainly in the diagnostics and pharmaceuticals businesses. Its segments include Diagnostics and Pharmaceuticals. In addition, it is a multinational biopharmaceutical and diagnostics company that is seeking to establish itself in large, rapidly growing markets.
On September 14, 2021, OPK and LeaderMed Health Group Limited announced their partnership to develop and commercialize two of OPK’s drug products. Phillip Frost, M.D., Chairman, and CEO of OPK, said, “Through this joint venture, we have an opportunity to extend the global availability of two of our novel long-acting development products and to establish a presence in…
Continue reading at STOCKNEWS.com